idiag

About:

Idiag is an interfacing research and development company converting innovative ideas on medical technology into ready-to-market products.

Website: http://www.idiag.ch

Top Investors: BioMedPartners, New Value, EPS Value Plus

Description:

Idiag is a specialist in interfacing research & development with sales and marketing. A central business aim is to convert innovative ideas on medical technology into products ready to market. Therefore Idiag offers to Universities and Innovation Centres, to take over final development, production and marketing for their unused medical product potential. Furthermore Idiag offers to manufacturer of high quality supplementing products, to act as reseller. Idiag then uses its existing resources, networks and excellence for market penetration and sales, within Switzerland and Germany.

Total Funding Amount:

$3.81M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Fehraltorf, Zurich, Switzerland

Founded Date:

1993-01-01

Contact Email:

info(AT)idiag.ch

Founders:

Number of Employees:

11-50

Last Funding Date:

2007-10-17

IPO Status:

Private

Industries:

© 2025 bioDAO.ai